These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9439869)

  • 1. Preliminary report of the use of sulfapyridine in the treatment of pneumonia. 1939.
    Plummer N; Ensworth H
    Bull N Y Acad Med; 1997; 74(2):355-62. PubMed ID: 9439869
    [No Abstract]   [Full Text] [Related]  

  • 2. Jesse Bullowa, specific treatment for pneumonia, and the development of the controlled clinical trial.
    Podolsky SH
    J R Soc Med; 2009 May; 102(5):203-7. PubMed ID: 19417054
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Zhanel GG; Hoban DJ; Chan CK
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12102063
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ethonium in the prevention and treatment of acute pneumonia].
    Lidvanskaia LS; Koren' VS
    Ter Arkh; 1978; 50(3):49-51. PubMed ID: 653595
    [No Abstract]   [Full Text] [Related]  

  • 5. The discovery of M & B 693 (sulfapyridine).
    Lesch JE
    Publ Am Inst Hist Pharm; 1997; 16():101-19. PubMed ID: 11619887
    [No Abstract]   [Full Text] [Related]  

  • 6. Amoxicillin versus sparfloxacin in the treatment of presumed pneumococcal pneumonia.
    Johnson JR
    Clin Infect Dis; 2000 Jan; 30(1):234-5. PubMed ID: 10619776
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Ross JJ; Worthington MG; Gorbach SL
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12097545
    [No Abstract]   [Full Text] [Related]  

  • 8. Historical and regulatory perspectives on the treatment effect of antibacterial drugs for community-acquired pneumonia.
    Singer M; Nambiar S; Valappil T; Higgins K; Gitterman S
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S216-24. PubMed ID: 18986293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Davidson R; Cavalcanti R; Brunton JL; Bast DJ; de Azavedo JC; Kibsey P; Fleming C; Low DE
    N Engl J Med; 2002 Mar; 346(10):747-50. PubMed ID: 11882730
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of quinolones against secondary pneumococcal pneumonia after influenza virus infection in mice.
    Hayashi K; Kadowaki SE; Takei M; Fukuda H
    Antimicrob Agents Chemother; 2006 Feb; 50(2):748-51. PubMed ID: 16436736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies in pneumonia and pneumococcus infection. 1904.
    Rosenow EC
    J Infect Dis; 2004 Jan; 189(1):132-64. PubMed ID: 14702163
    [No Abstract]   [Full Text] [Related]  

  • 12. Winston Churchill and M & B.
    Self AD
    J Med Biogr; 2001 Nov; 9(4):241. PubMed ID: 11595954
    [No Abstract]   [Full Text] [Related]  

  • 13. Present status of serum therapy in pneumonia. 1939.
    Cecil RL
    Bull N Y Acad Med; 1997; 74(2):341-54. PubMed ID: 9439868
    [No Abstract]   [Full Text] [Related]  

  • 14. Attacking the pneumococcus -- a hundred years' war.
    Swartz MN
    N Engl J Med; 2002 Mar; 346(10):722. PubMed ID: 11882726
    [No Abstract]   [Full Text] [Related]  

  • 15. Mea culpa.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2008 Aug; 5(8):409. PubMed ID: 18670441
    [No Abstract]   [Full Text] [Related]  

  • 16. Commentary:Rosenow EC. Studies in pneumonia and pneumococcus infection. J Infect Dis 1904; 1:280-312.
    Swartz MN
    J Infect Dis; 2004 Jan; 189(1):128-31. PubMed ID: 14986334
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluoroquinolones as pneumococcal therapy: closing the barn door before the horse escapes.
    Tillotson G; Zhao X; Drlica K
    Lancet Infect Dis; 2001 Oct; 1(3):145-6. PubMed ID: 11871490
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to: Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones.
    Rubinstein E
    J Antimicrob Chemother; 2003 May; 51(5):1307-8; author reply 1308-9. PubMed ID: 12697636
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging drugs for pneumococcal pneumonia.
    Falcó V; Sánchez A; Pahissa A; Rello J
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):459-77. PubMed ID: 21486118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [History and the significance of pneumonia in old age].
    Gsell O
    Z Gerontol; 1982; 15(6):325-31. PubMed ID: 6762785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.